The global vitro toxicology testing market accounted for a value of USD 7.4 billion in 2019 and it is projected to register growth at a CAGR of 19.5% during forecast period.
COVID-19 has impacted the vitro toxicology testing market. The demand for conducting faster testing is increasing around world. The demand and adoption of vitro toxicology testing technologies is increasing rapidly. Various in vitro testing kits have been approved for use in COVID-19 testing. There is decline in number of patient visiting hospitals or clinics on regular basis and this has hampered the market for vitro toxicology testing during pandemic. There is a supply shortage due to lockdown and travel restrictions. The market for vitro toxicology testing is likely to foresee boost from 2021.
For more details, visit: Global Vitro Toxicology Testing Market By Technology (OMICS Technology, Molecular Imaging, Others), By Application (Dermal Toxicity, Ocular Toxicity, Others.), By Method, By End-Users, By Region, Forecast & Opportunities to 2026
The adoption of vitro toxicology testing is increasing in the world. The animal testing is very costly and time consuming. Animal testing involves huge risks for animal’s life. The tests are conducted on rabbits and rodent model which involves risk of zoonotic diseases. Many countries have banned the animal testing and these countries have adopted vitro toxicology testing. This drives growth in vitro toxicology testing market during forecast period.
On the basis of technology, the vitro toxicology testing market is segmented into OMICS technology, molecular imaging, high throughput technology and cell culture technology. The cell culture technology accounted for largest market share in 2019. However, the OMICS technology is expected to grow at highest CAGR during forecast period. This technology offers personalized data which helps in providing better insights and it also reduces variability in data. It gives a clear and deeper understanding of toxicity of different sized materials. The high adoption of OMICS technology drives growth in this segment during forecast period.
On the basis of application, the vitro toxicology testing market is segmented into dermal toxicity, systemic toxicology, ocular toxicity, endocrine disruption and others. Systemic toxicology segment is had lead the market in 2019. However, the dermal toxicity segment is estimated to highest growing market during forecast period. The toxicology assays for dermal technology is cost-effective, reliable and simple. It helps in risk assessment and the technological advancement in dermal toxicity leads to increase in demand for dermal toxicity segment. This drives growth in dermal toxicity segment during forecast period.
On the basis of end-user, the vitro toxicology testing market is segmented into pharmaceutical industry, cosmetics & household products, diagnostics, food industry and chemicals industry. The pharmaceutical segment is estimated to hold largest market share during forecast period. The demand for vitro toxicology testing is highest in pharmaceuticals industry. It is used in analyzing generic and novel modified pharmaceutical products. There are various drugs which are in pipeline which requires vitro toxicology testing. This drives growth in pharmaceutical industry during forecast period.
Asia-Pacific region is expected to register growth at highest CAGR during forecast period. The governments in various regions are focusing on promoting the use of vitro toxicology testing methods. The demand for cost effective clinical trials is increasing in this region and vitro toxicology testing provides cost effective testing. Many companies are performing their drug test in Asia-Pacific region as the clinical trials are less costly than other countries. This drives growth in Asia-Pacific region during forecast period.
The key market players in vitro toxicology testing market are Thermo Fisher Scientific, Merck KGAA, Eurofins Scientific SE, GE Healthcare, Covance Inc., Charles River Laboratories, SGS S.A., Bio-Rad Laboratories, Qiagen N.V., Cyprotex Plc., Promega Corporation, Catalent Inc., Gentronix Inc., MB Research Laboratories, Bioivt, Creative Biolabs, Creative Biorray and Insphero.
- What are the expected industry trends over the next three to five years?
- Which of the vitro toxicology testing technology is likely to lead by 2025?
- Which of the end user segments is expected to have the maximum potential to during the forecast period?
- Which region is going to have the highest smart meters market share by 2025?
- What are different organic and inorganic strategies implemented by companies to gain increased market share?